ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding ImmunoGen, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 327 | 3 | 3 | −321 |
| Shares | 254.1M | 94.4K | 893 | −254.0M (−100.0%) |
| Value | $7.54B | $2.80M | $27.8K | −$7.53B (−100.0%) |
3 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held ImmunoGen, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mather Group, LLC. | 62 | $1.84K | 0.00% |
Sold out (322)
Institutions that held ImmunoGen, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Showing the largest 100 of 322 by value.
Not filed for Q1 2024 yet (3)
Institutions that held ImmunoGen, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Kellner Capital, LLC | 69,200 | $2.05M |
| Baystate Wealth Management LLC | 24,106 | $714.7K |
| Coppell Advisory Solutions LLC | 1,068 | $31.7K |